Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease

Stine Johansen; Mads Bastrup Israelsen; Katrine Prier Lindvig; Katrine Holtz Thorhauge; Johanne Kragh Hansen; Camilla Dalby Hansen; Ida Ziegler Spedtsberg; Helle Lindholm Schnefeld; Peter Andersen; Ida Falk Villesen; Katrine Tholstrup Bech; Nikolaj Christian Torp; Diana Julie Leeming; Torben Hansen; Morten  Karsdal; Maja Thiele; Aleksander Krag

doi:10.1016/S0168-8278(24)01811-7

Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease

Stine Johansen, Mads Bastrup Israelsen, Katrine Prier Lindvig, Katrine Holtz Thorhauge, Johanne Kragh Hansen, Camilla Dalby Hansen, Ida Ziegler Spedtsberg, Helle Lindholm Schnefeld, Peter Andersen, Ida Falk Villesen, Katrine Tholstrup Bech, Nikolaj Christian Torp, Diana Julie Leeming, Torben Hansen, Morten Karsdal, Maja Thiele, Aleksander Krag

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	FRI-017
Journal	Journal of Hepatology
Volume	80
Issue number	Suppl. 1
Pages (from-to)	S623-S624
ISSN	0168-8278
DOIs	https://doi.org/10.1016/S0168-8278(24)01811-7
Publication status	Published - 1. Jun 2024
Event	EASL Congress 2024 - Milan, Italy Duration: 5. Jun 2024 → 7. Jun 2024

Conference

Conference	EASL Congress 2024
Country/Territory	Italy
City	Milan
Period	05/06/2024 → 07/06/2024

Documents & Links

10.1016/S0168-8278(24)01811-7

Cite this

Johansen, S., Israelsen, M. B., Lindvig, K. P., Thorhauge, K. H., Kragh Hansen, J., Dalby Hansen, C., Spedtsberg, I. Z., Schnefeld, H. L., Andersen, P., Villesen, I. F., Bech, K. T., Torp, N. C., Leeming, D. J., Hansen, T., Karsdal, M., Thiele, M., & Krag, A. (2024). Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease. Journal of Hepatology, 80(Suppl. 1), S623-S624. Article FRI-017. https://doi.org/10.1016/S0168-8278(24)01811-7

@article{2f7060c609ff4bbf96b61e63c131a4b2,

title = "Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease",

author = "Stine Johansen and Israelsen, {Mads Bastrup} and Lindvig, {Katrine Prier} and Thorhauge, {Katrine Holtz} and {Kragh Hansen}, Johanne and {Dalby Hansen}, Camilla and Spedtsberg, {Ida Ziegler} and Schnefeld, {Helle Lindholm} and Peter Andersen and Villesen, {Ida Falk} and Bech, {Katrine Tholstrup} and Torp, {Nikolaj Christian} and Leeming, {Diana Julie} and Torben Hansen and Morten Karsdal and Maja Thiele and Aleksander Krag",

year = "2024",

month = jun,

day = "1",

doi = "10.1016/S0168-8278(24)01811-7",

language = "English",

volume = "80",

pages = "S623--S624",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "Suppl. 1",

note = "EASL Congress 2024 ; Conference date: 05-06-2024 Through 07-06-2024",

}

Johansen, S , Israelsen, MB , Lindvig, KP , Thorhauge, KH , Kragh Hansen, J , Dalby Hansen, C , Spedtsberg, IZ , Schnefeld, HL , Andersen, P , Villesen, IF , Bech, KT , Torp, NC, Leeming, DJ, Hansen, T, Karsdal, M, Thiele, M & Krag, A 2024, 'Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease', Journal of Hepatology, vol. 80, no. Suppl. 1, FRI-017, pp. S623-S624. https://doi.org/10.1016/S0168-8278(24)01811-7

Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease. / Johansen, Stine ; Israelsen, Mads Bastrup ; Lindvig, Katrine Prier et al.
In: Journal of Hepatology, Vol. 80, No. Suppl. 1, FRI-017, 01.06.2024, p. S623-S624.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease

AU - Johansen, Stine

AU - Israelsen, Mads Bastrup

AU - Lindvig, Katrine Prier

AU - Thorhauge, Katrine Holtz

AU - Kragh Hansen, Johanne

AU - Dalby Hansen, Camilla

AU - Spedtsberg, Ida Ziegler

AU - Schnefeld, Helle Lindholm

AU - Andersen, Peter

AU - Villesen, Ida Falk

AU - Bech, Katrine Tholstrup

AU - Torp, Nikolaj Christian

AU - Leeming, Diana Julie

AU - Hansen, Torben

AU - Karsdal, Morten

AU - Thiele, Maja

AU - Krag, Aleksander

PY - 2024/6/1

Y1 - 2024/6/1

U2 - 10.1016/S0168-8278(24)01811-7

DO - 10.1016/S0168-8278(24)01811-7

M3 - Conference abstract in journal

SN - 0168-8278

VL - 80

SP - S623-S624

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - Suppl. 1

M1 - FRI-017

T2 - EASL Congress 2024

Y2 - 5 June 2024 through 7 June 2024

ER -

Johansen S , Israelsen MB , Lindvig KP , Thorhauge KH , Kragh Hansen J , Dalby Hansen C et al. Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease. Journal of Hepatology. 2024 Jun 1;80(Suppl. 1):S623-S624. FRI-017. doi: 10.1016/S0168-8278(24)01811-7